[Form 4] NATIONAL HEALTHCARE CORP Insider Trading Activity
Rhea-AI Filing Summary
NATIONAL HEALTHCARE CORP director Emil E. Hassan received a new stock option grant as part of equity compensation. On May 7, 2026, he was granted options to purchase 7,500 shares of common stock at an exercise price of $171.42, vesting beginning May 7, 2027 and expiring May 6, 2031, under the 2020 Omnibus Equity Incentive Plan. Following this grant, he directly holds 73,095 shares of common stock and several prior option awards, each covering 7,500 shares at exercise prices of $94.66, $96.03, $55.75, and $69.19 with expirations from 2027 through 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
HASSAN EMIL E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Purchase Common Stock [2026 Grant] | 7,500 | $0.00 | $0.00 |
| holding | Option to Purchase Common Stock [2022 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2023 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2024 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2025 Grant] | -- | -- | -- |
| holding | Shares of Common Stock | -- | -- | -- |
Holdings After Transaction:
Option to Purchase Common Stock [2026 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2022 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2023 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2024 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2025 Grant] — 7,500 shares (Direct);
Shares of Common Stock — 73,095 shares (Direct)
Footnotes (1)
- F1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
AI-generated analysis. How Rhea-AI works. Not financial advice.
